Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4651
Santander
BSBR
$34.7B
| $23.1K | ﹤0.01% |
4,156
-30,164
| -88% | -$169K |
2026 Q2
1 quarter
|
|
4652
FT Vest US Equity Buffer ETF January
FJAN
$1.45B
| $23K | ﹤0.01% |
407
| – | – |
2026 Q2
1 quarter
|
|
4653
UP Fintech Holding
TIGR
$701M
| $23K | ﹤0.01% |
+5,010
| New | +$24.1K |
2026 Q3
0 quarters
|
|
4654
Outset Medical
OM
$79.8M
| $22.4K | ﹤0.01% |
7,471
-35,300
| -83% | -$144K |
2022 Q1
18 quarters
|
|
4655
CI&T Inc
CINT
$394M
| $22.2K | ﹤0.01% |
7,228
| – | – |
2025 Q1
6 quarters
|
|
4656
Brown-Forman Class A
BF.A
$14.4B
| $22K | ﹤0.01% |
820
+277
| +51% | +$7.6K |
2022 Q1
18 quarters
|
|
4657
Northern Technologies International Corp
NTIC
$70.7M
| $21.8K | ﹤0.01% |
2,803
-34
| -1% | -$275 |
2024 Q2
9 quarters
|
|
4658
AGF US Market Neutral Anti-Beta Fund
BTAL
$346M
| $21.6K | ﹤0.01% |
+1,797
| New | +$21.6K |
2026 Q3
0 quarters
|
|
4659
VivoPower PLC
VIVO
$63.7M
| $21.2K | ﹤0.01% |
+5,756
| New | +$23.6K |
2026 Q3
0 quarters
|
|
4660
BARK
BARK
$84.3M
| $20.9K | ﹤0.01% |
2,471
-600
| -20% | -$5.76K |
2022 Q1
18 quarters
|
|
4661
Karman Holdings
KRMN
$6.04B
| $20.9K | ﹤0.01% |
644
-17,178
| -96% | -$802K |
2025 Q2
5 quarters
|
|
4662
Vantage Corp
VNTG
$13.8M
| $20.8K | ﹤0.01% |
33,210
| – | – |
2025 Q4
3 quarters
|
|
4663
TTEC Holdings
TTEC
$68M
| $20.8K | ﹤0.01% |
15,986
-1,522
| -9% | -$2.68K |
2013 Q2
53 quarters
|
|
4664
PAMT Corp
PAMT
$293M
| $20.8K | ﹤0.01% |
1,819
+1,191
| +190% | +$16K |
2017 Q4
35 quarters
|
|
4665
Lipocine
LPCN
$12.9M
| $20.7K | ﹤0.01% |
9,415
-412
| -4% | -$910 |
2026 Q1
2 quarters
|
|
4666
UBS Group
UBS
$145B
| $20.6K | ﹤0.01% |
429
+119
| +38% | +$6.26K |
2024 Q4
7 quarters
|
|
4667
Reckoner Yield Enhanced AAA CLO Annual ETF
RAAY
$15.6M
| $20.6K | ﹤0.01% |
200
| – | – |
2026 Q1
2 quarters
|
|
4668
SIFCO Industries
SIF
$105M
| $20.5K | ﹤0.01% |
+907
| New | +$20.7K |
2026 Q3
0 quarters
|
|
4669
Empery Digital
EMPD
$59.6M
| $20K | ﹤0.01% |
+6,644
| New | +$21K |
2026 Q3
0 quarters
|
|
4670
Cryo-Cell International
CCEL
$39.4M
| $20K | ﹤0.01% |
4,759
+4,745
| +33,893% | +$18.2K |
2026 Q2
1 quarter
|
|
4671
eHealth
EHTH
$15.2M
| $19.9K | ﹤0.01% |
28,046
-64,165
| -70% | -$77.6K |
2016 Q4
39 quarters
|
|
4672
Banco Santander Chile
BSAC
$15.2B
| $19.9K | ﹤0.01% |
+596
| New | +$20.5K |
2026 Q3
0 quarters
|
|
4673
Swarmer Inc
SWMR
$101M
| $19.7K | ﹤0.01% |
1,107
+499
| +82% | +$17.7K |
2026 Q1
2 quarters
|
|
4674
Lee Enterprises
LEE
$147M
| $19.7K | ﹤0.01% |
2,838
+1,305
| +85% | +$10.3K |
2026 Q2
1 quarter
|
|
4675
LiveOne
LVO
$33.6M
| $19.7K | ﹤0.01% |
+7,593
| New | +$31.3K |
2026 Q3
0 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.